FindTrial
Sign In

Evaluation of Lactate Albumin Ratio and Procalcitonin Albumin Ratio as Prognostic Markers in Patients with Sepsis at a Tertiary Care Hospital

To Study Lactate Albumin Ratio and Procalcitonin Albumin ratio in patients with sepsis of KLE DR Prabhakar Kore Hospital and MRC - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109656
Enrollment
71
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

Intervention1: Nil: Nil

Sponsors

Jawaharlal Nehru Medical College and Hospital
Lead Sponsor
Aditya Shyam Jalan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients more than 18 years diagnosed with sepsis according to Sepsis 3 criteria upon admission

Exclusion criteria

Exclusion criteria: 1. Patients with known case of heart failure 2. known case of protein losing enteropathy and chronic malnutrition 3.Known case of Chronic liver disease 4. Patients already on Immunosuppressants drugs 5. Known case of Chronic kidney disease 6. Patients who received albumin or lactate containing fluid prior to admission 7. Known case of hematological and other malignant condition

Design outcomes

Primary

MeasureTime frame
To evaluate the prognostic significance of Lactate Albumin ratio and Procalcitonin Albumin ratio in patients with sepsisTimepoint: Day 1—

Secondary

MeasureTime frame
SOFA score calculationTimepoint: Day 1—

Countries

India

Contacts

Public ContactAditya Shyam Jalan

Jawaharlal Nehru Medical College

aditya.jalan9@gmail.com7002161136

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026